MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
Go back to MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures| MACROGENICS (NASDAQ: MGNX) | Delayed: 3.90 -0.22 (5.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.12 | 52 Week High | $36.11 | |||
| Open | $4.12 | 52 Week Low | $14.84 | |||
| Day High | $4.12 | P/E | 10.00 | |||
| Day Low | $3.88 | EPS | $0.39 | |||
| Volume | 130,064 | |||||
